Jennifer Riley

Chief Strategy Officer

Chief Strategy Officer at Avalo Therapeutics, Inc., filing insider transactions on 2026-08-11.

Total Purchases

—

0 transactions

Total Sales

$52K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-08-11

Last: 2026-08-11

Companies

Avalo Therapeutics, Inc.

Other Reporting Insiders at Avalo Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-11	AVTX	Sale	2,655	$19.59	$52K	37.0K	SEC ↗

Jennifer Riley (Avalo Therapeutics, Inc.) Insider Trades | Tormere